BILL ANALYSIS

S3846

NEUTRAL

Justice and Mental Health Collaboration Reauthorization Act of 2022

S3846 (Justice and Mental Health Collaboration Reauthorization Act of 2022) has been assessed with a neutral outlook for investors. The primary sectors impacted are Healthcare. View the full bill text on Congress.gov.

neutral

Market Sentiment

1/10

Impact Score

Sectors Impacted

Key Takeaways for Investors

The bill is signed into law; no further legislative action is pending.

No explicit funding amount is authorized; actual spending requires separate appropriations.

No publicly traded company is directly positioned to receive grant dollars; the impact on healthcare sector stocks is negligible.

The expansion of 988 hotline integration may marginally benefit telecom infrastructure providers, but the mechanism is indirect and not company-specific.

How S3846 Affects the Market

No direct market implications arise from this bill. The healthcare sector may see diffuse, long-term tailwinds as states allocate mental health funding, but no ticker-level signal exists. Investors should ignore this legislation for portfolio decisions.

Bill Details

Metric	Value
Bill Number	S3846
Market Sentiment	neutral
Event Date	December 27, 2022
Affected Sectors	Healthcare
Source	View on Congress.gov →

Summary

The Justice and Mental Health Collaboration Reauthorization Act of 2022 (Public Law 117-323) expands allowable uses of federal grants under the Justice and Mental Health Collaboration Program, including training for prosecutors, co-response teams, suicide prevention, case management, and 988 hotline integration. The bill is signed into law and authorizes no specific funding amount—actual appropriations are required for implementation. No publicly traded companies are directly identifiable as beneficiaries; funds flow to state, local, and tribal governments.

Full AI Market Analysis

The Justice and Mental Health Collaboration Reauthorization Act of 2022 was signed by the President on December 27, 2022, becoming Public Law 117-323. The bill reauthorizes and expands the Justice and Mental Health Collaboration Program, which provides grants to state, local, and tribal governments to improve criminal justice responses to individuals with mental health disorders. The law broadens allowable uses of grant funds to include training prosecutors on diversion programs, funding co-response teams (officers and mental health crisis workers), suicide prevention services for incarcerated individuals, case management for reentry, and integration of the 988 crisis hotline. However, the bill authorizes these programs without specifying a dollar amount—actual funding depends on annual appropriations. Since the bill is already law, there is no further legislative path. The money trail ends at government entities, not directly at public corporations. While mental health services providers (e.g., telehealth, correctional healthcare) may indirectly benefit if states sub-contract grant funds, the link is too diffuse and speculative to assign specific tickers. Structural dynamics: states may invest in training and technology, but public companies with clear revenue exposure to these specific grant categories are not identifiable from the bill's text. Investors should view this as a procedural reauthorization with no near-term market signal.